Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.
Yan H, Sun J, Wang K, Wang H, Wu S, Bao L, He W, Wang D, Zhu A, Zhang T, Gao R, Dong B, Li J, Yang L, Zhong M, Lv Q, Qin F, Zhuang Z, Huang X, Yang X, Li Y, Che Y, Jiang J.
Yan H, et al. Among authors: dong b.
Acta Pharm Sin B. 2021 Sep;11(9):2850-2858. doi: 10.1016/j.apsb.2021.02.024. Epub 2021 Mar 11.
Acta Pharm Sin B. 2021.
PMID: 33723501
Free PMC article.